Welcome : Guest

INSULIN DELIVERY SYSTEMS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Insulin Delivery Systems in US$ Million by the following major Insulin Delivery Mechanisms - Insulin Syringes, Insulin Pumps (External), and Insulin Pens. The report provides separate comprehensive analytics for US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. The report profiles 73 companies including many key and niche players such as -

Animas Corporation
Antares Pharma, Inc.
Becton, Dickinson and Company
Eli Lilly and Company
F. Hoffmann-La Roche, Ltd.

Click here to request a full list of companies covered in the report...

Code: MCP-6283
Price: $3950
Companies: 73
Pages: 426
Date: April 2010
Market Data Tables: 98
 



TABLE OF CONTENTS


  INSULIN DELIVERY SYSTEMS (Complete Report) Pages : 426   | $3950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Increasing Diabetes Prevalence – A Major Growth Propeller.....II-1
Diabetes – Taking Toll in Developing Countries.....II-1
1$100
   Insulin Therapy for Diabetes Management.....II-2
Insulin Delivery Systems – A Quick Market Primer.....II-2
1$100
   Insulin Pump Therapy: Convenient Alternate to Insulin Injection.....II-3
United States – The Largest Global Market for Insulin Pumps (External).....II-3
Rosy Future Ahead for Insulin Pens.....II-3
1$100
   Select Brands of Disposable Insulin Pens by Manufacturer.....II-4
Select Brands of Reusable Insulin Pens by Manufacturer.....II-4
Innovations in Insulin Delivery – An Overview.....II-4
Select Next-Generation Insulin Delivery Techniques and Devices.....II-4
Pulmonary Insulin Delivery via Inhalers.....II-4
1$100
   Early Jitters Make Pharma Majors Abandon Inhaled Insulin Research.....II-5
Pulmonary Insulin Delivery Research Still Remains Unabated.....II-5
1$100
   Transdermal Delivery of Insulin via Patches.....II-6
Transmucosal Insulin Delivery via Mouth Spray.....II-6
1$100
   Nasal Delivery of Insulin via Nasal Mucosa.....II-7
Hydrogels for Insulin Delivery.....II-7
Oral Insulin Delivery.....II-7
1$100
   Artificial Pancreas Technology – A Promising Approach for Diabetes Treatment.....II-8
Competitive Landscape.....II-8
Insulin Syringes.....II-8
1$100
   Insulin Pumps.....II-9
Insulin Pens.....II-9
1$100
   Pre-Filled Syringes: Gaining Diabetics Attention.....II-10
Insulin Pumps Market: Tough Ground for New Entrants.....II-10
Innovative Features Spruce Up the Market for Insulin Pumps.....II-10
2$125
   Combination Products: The Latest Trend in the Insulin Pump Market.....II-12
Implantable Insulin Pumps: Emerging Technology in the Insulin Pump Market.....II-12
Expiry of Warranty Provides New Opportunities to Insulin Pump Makers.....II-12
1$100
   Insulin Pump Market Issues.....II-13
Insulin Pump Training Not Receiving Adequate Attention.....II-13
Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged.....II-13
1$100
   Diabetes - A Fatal Disease.....II-14
Risk Factors for Diabetes.....II-14
Types of Diabetes.....II-14
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM).....II-14
1$100
   Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM).....II-15
Long Term Complications of Diabetes.....II-15
1$100
   Pancreas: The Main Source of Insulin in Human Body.....II-16
Types of Insulin & Administration.....II-16
1$100
   Oral Administration.....II-17
Goal of Insulin Therapy.....II-17
Insulin Delivery Systems – An Overview.....II-17
Insulin Syringes.....II-17
1$100
   Insulin Needles.....II-18
Insulin Pens.....II-18
1$100
   Advantages of Insulin Pens.....II-19
Disadvantages of Insulin Pens.....II-19
External Insulin Pumps.....II-19
Insulin Pump Components.....II-19
1$100
   How Does an Insulin Pump Work?.....II-20
Insulin Pump Delivery Rates.....II-20
Advantages of Insulin Pumps.....II-20
More Accurate and Consistent.....II-20
Adjusting Time Zones While Traveling.....II-20
1$100
   Enhances Blood Sugar Control in Pediatric Patients.....II-21
Improves Quality of Life.....II-21
Disadvantages of Insulin Pumps.....II-21
High Cost.....II-21
High Involvement.....II-21
Diabetic Ketoacidosis Risk.....II-21
Glucose Testing at Regular Intervals.....II-21
1$100
   Regular Rotation of Infusion Set.....II-22
Carrying Back-up Kit.....II-22
Regular Refilling of Pump.....II-22
Insulin Jet Injectors.....II-22
Pen Injectors.....II-22
1$100
   Nanotechnology Victoria, Monash University Develop SAW Generated Mechanism, for Insulin
  Delivery.....II-23
Medtronic Emphasizes Cutting-Edge Features of a Closed-Loop Diabetes Management System,
  Currently Under Development.....II-23
Toray Industries and Hoshi University Discover a New Approach for Insulin Delivery Via
  Nasal Spray.....II-23
1$100
   A New Study Demonstrates Superior Benefits of Novo Nordisk's Next Generation FlexPen
  over KwikPen and SoloStar.....II-24
Phosphagenics to Commence Phase II Clinical Trials of Transdermal Insulin Delivery
  System.....II-24
Oramed Pharmaceuticals Begins Phase Ia Trials of Insulin Suppository.....II-24
Debiotech and STMicroelectronics Unveil First Prototype of a Disposable Insulin
  Nanopump.....II-24
1$100
   Braunschweig University Scholar Devises Wristwatch Insulin Pump.....II-251$100
   Novo Nordisk Introduces Preloaded Pen.....II-26
BD Medical Unveils BD AutoShield Pen Needle.....II-26
Novo Nordisk Introduces Flexpen.....II-26
Polymedicure Unveils Insulin syringes.....II-26
Johnson & Johnson Medical India to Unveil Insulin Pumps.....II-26
Generex Rolls Out Oral Insulin Spray.....II-26
1$100
   Eli Lilly Launches KwikPen.....II-27
Smith Medical Launches Cozmo in China.....II-27
Medtronic Unveils Arabic Language Insulin Pump.....II-27
Medtronic Launches New Diabetes Monitoring System.....II-27
1$100
   Eli Lilly to Unveil New Insulin Pen, Memoir.....II-281$100
   JDRF Enters into Partnership with Animas.....II-29
Medtronic Acquires Certain Assets from PreciSense.....II-29
MannKind Inks Agreement to Acquire Pfizer’s German Insulin Facility.....II-29
Owen Mumford Inks Deal with Sanofi-Aventis.....II-29
1$100
   Medingo Obtains FDA Approval for Marketing Insulin Micropump.....II-30
Insulet Wins CE Mark Approval for OmniPod® Insulin Management System.....II-30
Sanofi-aventis Receives FDA Approval for Apidra® SoloSTAR®.....II-30
Novo Nordisk Receives FDA Approval for NovoLog® Labeling Change.....II-30
Patton Medical Devices, Unomedical Enter into Partnership Agreement.....II-30
1$100
   Sanofi-aventis Wins Canadian and EU Approval for ClikSTAR® Insulin Pen.....II-31
DexCom and Animas Amend Insulin Pump Joint Development Deal.....II-31
Medingo Secures FDA Approval for Solo MicroPump Insulin Delivery System.....II-31
Qualitest Pharmaceuticals Recalls Accusure Insulin Syringes.....II-31
Novartis Completes Acquisition of Nektar’s Pulmonary Business.....II-31
1$100
   Smiths Medical Acquires Zhejiang Zheda Medical Instrument.....II-32
ICBS Acquires Vectoris Pharma.....II-32
Sagent Pharma Acquires Rights to ChaSyr, a Multi-Chamber Syringe.....II-32
Novo Nordisk Hands Over Inhaled Insulin Patents to Aradigm.....II-32
Eli Lilly and Alkermes Terminate Inhaled Insulin Development Deal.....II-32
1$100
   Novo-Nordisk Drops Development Plan of Inhaled Insulin.....II-33
Generex, Dongsung Pharm Enter Agreement for Generex Oral-lyn.....II-33
Novo Nordisk Gains FDA Clearance for NovoLog®.....II-33
Novo Nordisk to Construct Insulin Plant in China.....II-33
Generex Biotechnology Enters into Distribution Agreement with SciGen.....II-33
1$100
   Rexam and Eli Lilly to Expand Manufacturing Base for Insulin Pens.....II-34
Merrion to Develop and Market Novo Nordisk’s Insulin Analogues.....II-34
Smiths Medical to Cease Insulin Pumps Sale, Exist Diabetes Business.....II-34
Covidien Recalls Mislabelled Syringes.....II-34
1$100
   Animas Recalls Insulin Pumps with Faulty Battery Cap.....II-35
NationsHealth Acquires Diabetes Care & Education.....II-35
Insulet Inks Agreement with DexCom.....II-35
Insulet Partners with Flextronics.....II-35
Debiotech Allies with STMicroelectronics.....II-35
1$100
   SpectRx Divests Insulin Pump Business.....II-361$100
   Animas Corporation (USA).....II-37
Antares Pharma, Inc. (USA).....II-37
1$100
   Becton, Dickinson and Company (USA).....II-38
Eli Lilly and Company (USA).....II-38
1$100
   F. Hoffmann-La Roche, Ltd. (Switzerland).....II-39
Disetronic Medical Systems, Inc. (USA).....II-39
1$100
   Generex Biotechnology Corp. (Canada).....II-40
Insulet Corp. (USA).....II-40
Medical Plastic Devices Inc. (Canada).....II-40
1$100
   Medtronic Inc. (USA).....II-41
Novo Nordisk A/S (Denmark).....II-41
1$100
   Patton Medical Devices, LP (USA).....II-42
Sanofi-Aventis (France).....II-42
Smiths Medical MD, Inc. (USA).....II-42
1$100
   Ypsomed AG (Switzerland).....II-431$100
   Insulin Syringes:.....II-44
Table 1: World Recent Past, Current & Future Analysis for Insulin Syringes Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-44
1$350
   Table 2: World Historic Review for Insulin Syringes Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-451$350
   Table 3: World 13-year Perspective for Insulin Syringes Market by Geographic Region - Percentage Breakdown of Value Sales for US, Europe and Rest of World Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....II-461$350
   Insulin Pumps (External):.....II-47
Table 4: World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-47
1$350
   Table 5: World Historic Review for Insulin Pumps (External) Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-481$350
   Table 6: World 13-year Perspective for Insulin Pumps (External) Market by Geographic Region - Percentage Breakdown of Value Sales for US, Europe and Rest of World Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....II-491$350
   Insulin Pens:.....II-50
Table 7: US and Europe Recent Past, Current & Future Analysis for Insulin Pens Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-50
1$350
   Table 8: US and Europe Historic Review for Insulin Pens Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-511$350
   A. Market Analysis.....III-1
Diabetes – A Cause of Concern.....III-1
Table 9: Diabetes Prevalence by Diabetes Type in Millions in the US (2008) (includes corresponding Graph/Chart).....III-1
Surging Diabetic Population Keeps Demand Ticking for Insulin Delivery
  Systems.....III-1
1$200
   External Insulin Pumps: A Key Mechanism for Insulin Delivery.....III-2
Insulin Pens Gaining Immense Prominence.....III-2
Jet Injectors: The Costliest Insulin Delivery System.....III-2
1$75
   Competitive Analysis by Insulin Delivery System.....III-3
Becton Dickinson – The Insulin Syringes Market Leader.....III-3
Table 10: US Insulin Syringes Market (2007): Percentage Share Breakdown by Leading Companies - Becton Dickinson, Kendall, and Others (includes corresponding Graph/Chart).....III-3
Medtronic – The Insulin Pumps Major.....III-3
Table 11: US Insulin Pumps Market (2008): Percentage Share Breakdown of Leading insulin Pump Manufacturers - Medtronic, Animas and Others Comparison of Major Insulin Pump Systems Based on Select Parameters (includes corresponding Graph/Chart).....III-3
1$200
   Product Introductions.....III-41$75
   Strategic Corporate Developments.....III-55$225
   Major Players.....III-104$175
   B. Market Analytics.....III-14
Table 12: US Recent Past, Current & Future Analysis for Insulin Delivery Systems - Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-14
1$200
   Table 13: US Historic Review for Insulin Delivery Systems - Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-151$200
   Table 14: US 13-year Perspective for Insulin Delivery Systems - Percentage Breakdown of Value Sales for Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....III-161$200
   A. Market Analysis.....III-17
European Preference for Insulin Pens Overshadows the Rest of the World
  Demand.....III-17
Insulin Pump Therapy Gaining Favor Among Europeans.....III-17
1$75
   Strategic Corporate Developments.....III-181$75
   Major Players.....III-192$125
   B. Market Analytics.....III-21
Table 15: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems - Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-21
1$200
   Table 16: Europe Historic Review for Insulin Delivery Systems - Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-221$200
   Table 17: Europe 13-year Perspective for Insulin Delivery Systems - Percentage Breakdown of Value Sales for Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....III-231$200
   A. Market Analysis.....III-24
Product Introductions.....III-24
1$75
   Strategic Corporate Developments.....III-251$75
   Major Players.....III-262$125
   B. Market Analytics.....III-28
Table 18: Rest of World Recent Past, Current & Future Analysis for Insulin Delivery Systems - Insulin Syringes and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-28
1$200
   Table 19: Rest of World Historic Review for Insulin Delivery Systems - Insulin Syringes and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-291$200
   Table 20: Rest of World 13-year Perspective for Insulin Delivery Systems - Percentage Breakdown of Value Sales for Insulin Syringes and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart).....III-301$200
  
Total Companies Profiled: 72 (including Divisions/Subsidiaries - 82)

Region/Country Players

The United States 34 Canada 2 Japan 2 Europe 10 France 1 Germany 1 The United Kingdom 2 Rest of Europe 6 Asia-Pacific (Excluding Japan) 31 Middle-East 3
Click here to request a full table of contents and more details on this project.